Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
WADA's rationale is that BPC-157 is a pharmacological substance not approved for human therapeutic use by any regulatory authority, and its tissue repair properties could provide a performance-enhancing benefit
GHK-Cu is sold by Omnix Peptides strictly for laboratory, research, or analytical purposes
Theoretical Considerations Both peptides strongly promote new blood vessel growth
Multi-Peptide Synergy : Three distinct peptides targeting complementary signaling pathwaysnitric oxide and growth factor regulation (BPC-157), metalloprotein activity and redox signaling (GHK-CU peptide), and actin-binding dynamics (TB500)enabling investigation of coordinated biological responses
US$ 23.83
US$ 20.84
US$ 21.23
